Peroxiredoxins are a family of six antioxidant enzymes (PRDX1-6), and may be an alternative system for the pancreatic beta cells to cope with oxidative stress. This study investigated whether the main diabetogenic pro-inflammatory cytokines or the anti-inflammatory cytokine IL-4 modulate PRDXs levels and putative intracellular pathways important for this process in the insulin-producing RINm5F cells. RINm5F cells expressed significant amounts of PRDX1, PRDX3 and PRDX6 enzymes. Only PRDX6 was modulated by cytokines, showing both mRNA and protein down-regulation following incubation of RINm5F cells with TNF-alpha and IFN-gamma but not with IL-1beta. Separately IFN-gamma or TNF-alpha decreased PRDX6 protein but not mRNA levels. The blockage of the JNK signalling and of the calpains and proteasome proteolysis systems restored PRDX6 protein levels. IL-4 alone did not modulate PRDXs levels. However, pre/co-incubation with IL-4 substantially prevented the decrease in PRDX6 induced by proinflammatory cytokines. Knockdown of PRDX6 increased susceptibility of RINm5F cells to the deleterious effects of pro-inflammatory cytokines and to oxidative stress. These results show that, from the PRDXs significantly expressed in RINm5F cells, only PRDX6 is modulated by the diabetogenic cytokines IFNgamma and TNF-alpha. This PRDX6 down-regulation depends on the calpain and proteasome systems and JNK signalling. PRDX6 is an important enzyme for protection against oxidative stress and the interaction between pro-and anti-inflammatory cytokines might be important to determine the antioxidant capacity of the cells.
Introduction
Type 1 Diabetes is a multifactorial disease characterized by chronic inflammation and beta cell loss (Lenzen, 2008; Moore et al., 2011; Pirot et al., 2008) . Pro-inflammatory cytokines, such as IL-1beta, TNF-alpha and IFN-gamma induce the generation of reactive oxygen and nitrogen species (ROS and RNS) by pancreatic beta cells, leading ultimately to beta cell death (Lenzen, 2008; Souza et al., 2008) . This occurs due to the vulnerability of beta cells to oxidative stress, owing to their low antioxidant capacity. Beta cells express low amounts of both glutathione peroxidase and particularly catalase, enzymes in charge of converting hydrogen peroxide (H 2 O 2 ) into water (H 2 O) (Lenzen, 2008; Lenzen et al., 1996) . Therefore, it may be hypothesized that beta cells may have evolved to use additional systems to get rid of H 2 O 2 and other related peroxide compounds. Peroxiredoxins (PRDXs) are a new family of thiol-specific antioxidant proteins that exert their effects via their peroxidase activity (ROOH + 2e À ? ROH + H 2 O), whereby H 2 O 2 , peroxynitrite and a wide range of organic hydroperoxides are reduced and detoxified (Peshenko and Shichi, 2001) . At least six PRDXs were identified in mammalian cells and distributed in most cell compartments. PRDX1, 2 and 6 are localised particularly in the cytosol, PRDX3 is expressed mainly in mitochondria, PRDX4 is located in endoplasmic reticulum and also secreted extracellularly and PRDX5 is located in mitochondria and peroxisomes (Wood et al., 2003) . PRDXs are divided into 3 classes: PRDX1 to 4 0303-7207/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mce.2013.04.009
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are the typical 2-Cys subgroup and exhibit two conserved motifs centred on Cys residues, one in the C-terminus and one in the Nterminus; PRDX5 differs because its C-terminus cysteine is not in the conserved position and PRDX6 conserves only the N-terminus cysteine (Wood et al., 2003) .
It has already been shown that pro-inflammatory cytokines have a more hazardous effect on pancreatic beta cells and insulin-producing beta cells when they act in combination (Souza et al., 2008) . The cytokine toxicity is partly due to the marked production of nitric oxide (NO) through induction of inducible nitric oxide synthase (iNOS) by the beta cells, particularly when cells are exposed to IL-1beta (Souza et al., 2008) . However, there is opposing data suggesting that beta cell damage induced by pro-inflammatory cytokines is not related to the iNOS pathway (Todaro et al., 2003) , and possibly in this case cytotoxicity is due to oxidative stress only, with no participation of nitrosative stress. Pro-inflammatory cytokines also modulate apoptotic pathways, the expression and/or activity of antioxidant enzymes and transcription factors such as caspase-3, manganese superoxide dismutase (MnSOD), catalase, signal transducer and activator of transcription 1 (STAT1), and nuclear factor kappa B (NF-kappaB) (Moore et al., 2011; Ortis et al., 2010; Souza et al., 2008) . In contrast, anti-inflammatory cytokines are able to counteract many of the effects of IL-1beta, reducing NO production and granting cellular protection (Kaminski et al., 2007 (Kaminski et al., , 2010 Souza et al., 2008) .
The aim of the present study was to investigate whether proinflammatory cytokines modulate the PRDX system at mRNA and protein levels and whether there exists any interaction between anti-and pro-inflammatory cytokines in this modulation in insulin-producing RINm5F cells. We demonstrated that IFN-gamma and TNF-alpha strongly reduce PRDX6 levels, while all other PRDXs are not modulated by cytokines. Activation of calpain, c-Jun N-terminal kinase (JNK) and proteasome pathways were also major features of RINm5F cells exposed to pro-inflammatory cytokines. Remarkably, IL-4 was able to reverse these effects. We suggest that the decrease in the PRDX6 levels could contribute to the mechanism of pro-inflammatory cytokine-dependent cytotoxicity in insulin-producing cells in the specific situation of IFN-gamma/ TNF-alpha attack.
Methods

Materials
Recombinant rat IFN-gamma, TNF-alpha and IL-1beta cytokines were from Invitrogen Corp (Carlsbad, CA, USA). Recombinant rat IL-4 was from Thermo Scientific (Miami, OK, USA). All SDS-PAGE and immunoblotting equipment's were from Bio-Rad systems (Richmond, CA, USA). Anti-PRDX1, anti-PRDX2, anti-PRDX3, anti-PRDX4, anti-PRDX5 and anti-PRDX6 were from Abcam Inc. (Cambridge, MA, USA). Anti-GAPDH was from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-phospho c-Jun ser 63 and anti-phospho c-Jun ser 73 were from Cell Signalling Technology (Beverly, MA, USA). Calpain (N-Acetyl-L-leucyl-L-leucyl-L-norleucinal, catalogue number A6185), JNK (SP600125, c. number S5567), NF-kappaB (ammonium pyrrolidine dithiocarbamate, PDTC, c. number P8765), and STAT1 (curcumin, c. number 08511) inhibitors, RPMI 1640 medium and other culture reagents were from Sigma Chemicals Co (St. Louis, MO, USA). MTS reagent was from Promega (Madison, WI, USA). Proteasome inhibitor (MG132, catalogue number E1B1748) was from Enogene Biotech Co. (New York, NY, USA). SYBR Green Master Mix and other PCR reagents were from Applied Biosystems (Foster City, CA, USA). PCR primers were acquired from IDT (Coralville, IA, USA) and the sequences are presented in Supplementary Table S1 .
Cell culture
RINm5F cells at passages 80-90 were cultured in RPMI 1640 medium, supplemented with 11 mmol/L glucose, 10% foetal calf serum, 1% penicillin and streptomycin in a humidified atmosphere at 37°C and 5% CO 2 . Cells were plated and cultured until 80% confluence. Subsequently, cells were exposed to 14 or 140 U/mL of IFN-gamma, 185 or 1850 U/mL of TNF-alpha, 60 or 600 U/mL of IL-1beta and 2, 20 or 50 ng/mL of IL-4. Exposure to hydrogen peroxide was made in antibiotic-free/serum-free medium. After 2 h H 2 O 2 incubation, antibiotics (1%) and serum (final concentration of 10%) were added and viability measured 22 h later. When required, inhibitors or PRDX6 siRNA were added to the medium. Control cells were grown in RPMI 1640 medium without addition of test compounds.
Western-blotting
Control and cytokine-incubated cells were homogenized by sonication in ice-cold medium containing 8 mmol/L urea and centrifuged at 12,000 g, 4°C for 15 min. Supernatants were collected and Laemmli buffer (62.5 mmol/L Tris-HCl, pH 6.8; 25% glycerol; 2% SDS; 0.01% Bromophenol Blue; 10 mmol/L DTT; without 2-mercaptoethanol) was added to samples. For PRDX1, PRDX3, PRDX6, p-c-Jun ser 63 and p-c-Jun ser 73, 30 lg of the total protein from the supernatants were heated at 100°C for 5 min, resolved by electrophoresis in 10% SDS-polyacrylamide gel and electro-blotted onto nitrocellulose membranes. For PRDX2, PRDX4 and PRDX5, 50 lg of protein were used instead. After blocking in 5% non-fat milk solution for 2 h, immunodetection was performed after overnight incubation with a PRDX1 antibody (1:1000 dilution), PRDX3 antibody (1:300 dilution), PRDX6 antibody (1:1000 dilution), p-cJun ser 63 and ser 73 antibodies (1:1000 dilution), PRDX2, PRDX4 and PRDX5 antibodies (1:500 dilution). GAPDH antibody (1:1000 dilution) was used as a loading control. Membranes were then exposed to 150 ng/mL specific secondary peroxidase-conjugated antibody (anti IgG (H + L)-HRP, Invitrogen) for 2 h at room temperature and visualized by chemiluminescence (SuperSignal, Pierce Biotechnology Inc., Rockford, IL, USA). The bands were quantified using the Scion Image software (Scion Corp., Frederick, MD, USA).
RNA extraction and quantitative real-time PCR
RINm5F cells were collect in 1 mL of TRIzol reagent (Invitrogen). Total RNA was isolated according to the manufacturer's guidelines and quantified by a spectrophotometer. The purity and integrity of RNA was verified by agarose gel electrophoresis. Complementary DNA was prepared using 3 lg of total RNA and MultiScribe reverse transcriptase™ (Applied Biosystems). GAPDH was used as a housekeeping gene. Real-time PCR was carried out in the StepOne thermocycler (Applied Biosystems). The PCR conditions were 95°C for 10 min, followed by 40 cycles at 95°for 10 s and 60°C for 30 s. Real-time PCR data were analysed using the Sequence Detector System 1.7 (Applied Biosystems).
MTS cell viability assay
For estimation of toxicity of IFN-gamma, TNF-alpha, H 2 O 2 , and of the calpain inhibitor, the number of viable cells was determined by the colorimetric method of reduction of tetrazolium salt into soluble formazan, according to the manufacturer's instructions. The viability was expressed as% of the MTS absorbance at 490 nm in the absence of tested compound (control cells).
JNK and PRDX6 siRNA transfection
RINm5F cells were seeded on 24-well culture plates until reaching 80% confluence. Thereafter, cells were transfected using Lipofectamine 2000 (Invitrogen) with either 100 or 200 nmol/L (final concentration) siRNA raised against JNK or against PRDX6 according to manufacturer's instructions. A time-dependent curve was performed before cell viability experiments. Sequences of the JNK siRNA (Stealth Select siRNA Duplex Oligoribonucleotides, InVitrogen, Pasley, UK) used were AAAGAAUGUCCUACCUUCU (sense) and AGAAGGUAGGACAUUCUUU (anti-sense). Sequences of the PRDX6 siRNA (Silencer Select Pre-designed siRNA, Life Technologies do Brasil LTDA., São Paulo, Brazil) used were GGAAACCUCAGGUCUUGUAtt (sense) and UACAAGACCUGAGGUUUCCtc (anti-sense). Tests using a non-targeting RNA sequence (Control siRNA-A, Santa Cruz Biotechnology, Inc.; catalogue number sc-37007) were made in pre-experiments, and showed that there were no changes on the results of PRDX6 levels at any of our conditions (not shown). Therefore, mock transfections were used as control thereafter. Cells were harvested for western-blotting measurements after 48, 72, and/or 96 h of transfection, as indicated in the figures.
Statistics
All data are expressed as mean ± SEM. Statistical analyses were performed using One-way or Two-way ANOVA followed by either Bonferroni's or Dunnett's test, as required. Letters above bars denote significant differences among groups when letters are dissimilar (''a'' is statistically different from ''b'', ''c'', ''d'', and so forth; while a group with an ''a'' on the top of the bar is statistically not different of another group with an ''a'' on the top of the bar within the same set of experiment; the same for ''b'' equal ''b'', ''c'' equal ''c'', and so forth). Only groups where differences were found were marked accordingly. P < 0.05 was considered statistically significant.
Results
Effect of IL-1beta, TNF-alpha and IFN-gamma on the PRDXs mRNA and protein levels in insulin-producing RINm5F cells
Exposure of insulin-producing RINm5F cells to 60 or 600 U/mL of IL-1beta, 185 or 1850 U/mL of TNF-alpha and 14 or 140 U/mL of IFN-gamma for 6 and 24 h did not change the mRNA levels of any of the PRDX isoforms (Supplementary data in Table S2 ). The incubation time and concentrations of the cytokines used were based on previous studies (Souza et al., 2004 (Souza et al., , 2008 . Likewise, incubation with these cytokines for 6 and 24 h did not modulate the levels of PRDX1 (Supplementary Fig. S1A and S1B) and PRDX3 (Supplementary Fig. S1C and S1D) proteins. No changes were observed in the PRDX6 protein level after 6 h of cytokine exposure (Fig. 1A) . However, there were reductions of 49 ± 9% and 58 ± 11% in the PRDX6 levels after 24 h of incubation with 1850 U/mL TNF-alpha and 140 U/mL IFN-gamma, respectively (Fig. 1B) . Of note, we were not able to detect any of the PRDX2, PRDX4 or PRDX5 isoforms at the protein level in RINm5F cells, even using higher amounts of loaded protein (50 lg) (Supplementary Fig. S1E ). Attempts to detect PRDX2 with a distinct antibody (Epitomics, Burlingame, CA, USA, c. number 3539-1, dilution 1:1000) and high amount of loaded protein were made, but still there were no visible bands after normal western-blotting development (1 min exposition time to autoradiograms); (Supplementary Fig. S2 , left panel). Using very long exposition time to autoradiograms (1 h) faint bands were barely detect (Supplementary Fig. S2 , right panel). Hence, it was clear that the amount of PRDX2 was at or below of detection limits of both the methodology and the antibody, and we can assure with good degree of certainty that RINm5F cells does not constitutively express significant amounts of this protein. Although not explored in this work, the same might be true to PRDX4 and PRDX5.
We also confirmed the results on PRDX6 protein down-regulation in another pancreatic beta cell line, namely INS1-E, which showed the same pattern of PRDX6 protein level decrease after incubation with 1850 U/mL TNF-alpha and 140 U/mL IFN-gamma alone or in combination ( Supplementary Fig. S3 ). Of note, again reproducing the RINm5F pattern, incubation of INS1-E cells with IL-1beta also did not decrease PRDX6 levels (Fig. S3) . Since no differences were found in PRDXs levels after incubation of RINm5F cells with IL-beta, we also tested whether our cells were responding to this cytokine as expected. It has been previously reported that IL-1beta strongly increase iNOS expression (Souza et al., Results are presented as mean ± S.E.M., compared against control values obtained from cells incubated without cytokines. Different letters indicate statistically significant differences. Every 3 groups comprise a set of experiment and was statistically analysed separated from the others, and marked accordingly with the letters. When no differences were found, no letter was assigned to the group. P < 0.05; One-way ANOVA followed by Bonferroni.
2008), and this was taken as a parameter for evaluation of IL-1beta sensitivity. There was a marked increase in iNOS expression after incubation of RINm5F cells with 600 U/mL of IL-1beta (Supplementary Fig. S4, upper panel) , similar to that found after incubation of INS1-E cells (Fig. S4, lower panel) , confirming the sensitivity of these cells to IL-1beta.
3.2. Effect of the combination of TNF-alpha and IFN-gamma on the PRDX6 mRNA and protein levels in insulin-producing RINm5F cells
Since there was a reduction in PRDX6 protein level after incubation with TNF-alpha or IFN-gamma, separately, we analysed RINm5F cells exposed to a combination of TNF-alpha and IFN-gamma for 24 h. PRDX6 protein level did not change in cells incubated with TNF-alpha + IFN-gamma at the lowest concentrations (185 + 14 U/mL), but at the highest concentrations (1850 + 140 U/ mL), we observed a significant decrease of 59 ± 5%, compared to control cells ( Fig. 2A) . PRDX6 mRNA level was not altered by TNF-alpha and IFN-gamma, separately or in combination, at the lower concentrations. However, at the highest concentration, there was a marked reduction of 65 ± 5% in the PRDX6 mRNA level (Fig. 2B ). This result indicates that modulation in PRDX6 at the transcriptional level is more complex, and may require the activation of major intracellular signalling pathways. To confirm this hypothesis, insulin-producing RINm5F cells were pre-incubated with pyrrolidine dithiocarbamate (PDTC), a pharmacological inhibitor of NF-kappaB translocation into the nucleus, which is known to be a crucial pathway in pro-inflammatory cytokine signalling on beta cells (Pirot et al., 2008; Souza et al., 2008) . The concentration and time of incubation of this inhibitor has been previously described (Paula et al., 2010) . After blockage of NF-kappaB translocation, no reduction in the PRDX6 mRNA level was observed in RINm5F cells incubated with TNF-alpha + IFN-gamma, indicating that the activation of NF-kappaB is necessary for decreasing PRDX6 mRNA level (Fig. 2C) . Other major pathways were also involved in the modulation of PRDX6 mRNA by the combination of IFN-gamma plus TNF-alpha. The blockade of STAT1 using curcumin and of JNK pathway using SP600125 inhibitors recovers PRDX6 mRNA, albeit showing a slightly lower capacity of recovering compared to the blockade of NF-kappaB (Fig. 2C) . It is important to mention here, that our results do not definitely proved that the reduction in mRNA level translates into reduced protein level or the mechanism of this decrease in mRNA level, which could be either by decreased mRNA expression or increased mRNA degradation. On the other hand, it has been previously proposed that alterations in the mRNA levels mirrors the protein levels in pancreatic islets (Cardozo et al., 2003) , corroborating the idea that mRNA levels might determine the PRDX6 protein level in the context of our work. However, proteolysis could also be an alternative route for control of protein expression (Mukhopadhyay et al., 2006; Roumes et al., 2010; Seo et al., 1999) , and we thus decided to test this possibility for PRDX6 modulation in RINm5F cells exposed to the diabetogenic cytokines.
3.3. Modulation of PRDX6 protein level by TNF-alpha and IFN-gamma in insulin-producing RINm5F cells requires calpain and proteasome proteolysis systems Viability was measured by the MTS test in order to determine the ideal concentration and time of exposure of the calpain inhibitor. A time-and dose-dependent curve was performed, and, based on the results (Fig. 3A) , the concentration chosen was 10 lmol/L. For the proteasome inhibitor (MG 132), 10 lmol/L was added to the culture medium. This concentration was selected on the basis of previously published study (Kwon et al., 1998) . There was a reduction in the PRDX6 protein level of approximately 50% when RINm5F cells were incubated with TNF-alpha and IFN-gamma for 24 h (Fig. 3B and C) . The blockage of Calpain (Fig. 3B ) and proteasome (Fig. 3C ) proteolysis systems completely restored the PRDX6 protein level in cells incubated with TNF-alpha and IFN-gamma alone. When both cytokines were used in combination, inhibition of these proteolytic pathways clearly (but not totally) restored the PRDX6 protein intracellular level. Fig. 2 . Effect of IFN-c + TNF-a cytokines on the PRDX6 protein and mRNA levels in insulin-producing RINm5F cells. RINm5F cells were seeded 24 h before incubation with IFN-c and TNF-a alone or in a combination for 24 h. After this period, cells were lysed and used for Western-Blotting or real-time PCR analyses. (A) The PRDX6 protein, (B) mRNA levels were analyzed after exposure of cells with cytokines and (C) the PRDX6 mRNA was analysed after cells were exposed to cytokines in the presence or absence of PDTC, STAT1 inhibitor or JNK inhibitor. Different letters indicate statistically significant differences among each treatment. P < 0.001. Data are expressed as mean ± S.E.M., normalised to the housekeeping GAPDH and represent 4 independent. Two-way ANOVA followed by Bonferroni.
Contribution of JNK signalling to the TNF-alpha-and IFN-gammainduced decrease in PRDX6 protein level in insulin-producing RINm5F cells
We also tested the involvement of JNK signalling in the modulation of PRDX6 levels. To confirm the efficiency of the JNK inhibitor (SP600125) used in the tests, the phosphorylation of the transcription factor, c-Jun, the direct substrate of JNK, on serine 63 and serine 73 was analysed. There was a significant reduction in these two c-Jun phosphorylation sites after the blockage of JNK (Fig. 4A) . Blockage of the JNK pathway abolished the reduction in the PRDX6 protein intracellular level induced by TNF-alpha and IFN-gamma (Fig. 4B) . These results were confirmed using an siRNA raised against JNK1. As shown in Fig. 5 , down-regulation of JNK1 also restores PRDX6 protein expression levels. It is of note here, that the recovery of PRDX6 protein quantity after blockade of JNK pathway might involve restoration of mRNA levels (as shown in Fig. 2C ), which in turn might be related to c-Jun phosphorylation pattern.
Effect of IL-4 cytokine on the PRDXs mRNA levels and PRDX1, PRDX3 and PRDX6 protein levels in insulin-producing RINm5F cells
To evaluate whether the anti-inflammatory cytokine IL-4 modulates PRDXs mRNA levels, insulin-producing RINm5F cells were incubated with different concentrations of IL-4 (2, 20 and 50 ng/ mL) for 6 and 24 h. There was no effect of IL-4 alone on the mRNA levels of any of the PRDXs isoforms (Supplementary data in Table S3 ) and on the PRDX1, PRDX3 (Supplementary Fig. S5A and S5B) and PRDX6 (Fig. 6) protein levels. itor. RINm5F cells were seeded 24 h before exposure to 1, 10, 50 and 100 lmol/L of calpain inhibitor for 6, 24 and 48 h. Control cells are grown in the absence of the inhibitor. MTS conversion to a soluble formazan product by viable cells was determined by a kinetic measurement of absorbance at 490 nm. N = 7. Different letters indicate statistically significant differences. P < 0.01. One-way ANOVA followed by Dunnett, (B) pre-incubation with the calpain inhibitor blocks the reduction on the PRDX6 protein level induced by IFN-c and TNF-a in insulinproducing RINm5F cells. RINm5F cells were seeded 24 h before incubation with IFN-c and TNF-a for 24 h in the presence or absence of 10 lmol/L calpain inhibitor and (C) effect of blockage of proteasome system on the PRDX6 protein level in insulin-producing RINm5F cells exposed to IFN-c and TNF-a. RINm5F cells were seeded 24 h before incubation with IFN-c and TNF-a for 24 h in the presence or absence of 10 lmol/L specific proteasome inhibitor, MG132. After incubation period, cells in (B) and (C) were lysed and used for Western-Blotting analyses. Blots represent 4 independent experiments, normalised to the housekeeping protein GAPDH. Results are presented as mean ± S.E.M. Different letters indicate statistically significant differences. P < 0.001. Two-way ANOVA followed by Bonferroni. 3.6. Interactions between anti-and pro-inflammatory cytokines on the PRDX6 mRNA and protein levels in insulin-producing RINm5F cells Pre-incubation with 50 ng/mL of the anti-inflammatory cytokine IL-4 for 24 h prevented the reduction in the PRDX6 protein level induced by the incubation with TNF-alpha and IFN-gamma separately and partially prevented the effect when the combination of both pro-inflammatory cytokines was used instead (Fig. 7A) . The decrease in the PRDX6 mRNA levels mediated by the exposure of RINm5F cells to the TNF-alpha and IFN-gamma mixture was completely blocked when RINm5F cells were preincubated with IL-4 (Fig. 7B). 3.7. Knockdown of PRDX6 by small interfering RNA (siRNA) decreases cellular resistance against both pro-inflammatory cytokines and hydrogen peroxide PRDX6 siRNA was very effective in decreasing PRDX6 level, with maximal effectiveness at 100 nmol/L after 96 h of incubation (Fig. 8A) . Subsequent experiments were made using this PRDX6 siRNA concentration and time of exposure. Exposure of RINm5F cells to 140 U/mL of IFN-gamma or to 1850 U/mL of TNF-alpha resulted in a decrease in cellular viability of 32 ± 6% or 31 ± 6%, respectively (Fig. 8B, black bars) . Exposure to both cytokines in combination resulted in an even greater decrease in cellular viability of 49 ± 4% (Fig. 8B, black bar) . The knockdown of PRDX6 renders the cells much more vulnerable to the deleterious effects of both cytokines, especially to TNF-alpha, with decreases of 63 ± 4%, JNK-dependent phosphorylation of the transcription factor c-Jun on ser63 and ser73 after exposure to IFN-gamma and TNF-alpha and (B) effect of the knocking down of JNK1 on the PRDX6 protein level in insulin-producing RINm5F cells exposed to IFNgamma and TNF-alpha. Results are presented as mean ± S.E.M. Different letters indicate statistically significant differences. P < 0.05. Two-way ANOVA followed by Bonferroni. Fig. 6 . Effect of IL-4 on the PRDX6 protein level in insulin-producing RINm5F cells. RINm5F cells were seeded 24 h before incubation with 2, 20 and 50 ng/mL of IL-4 for 6 and 24 h. After this period, cells were lysed and used for the Western-Blotting analyses. Blots on the top are representative of 6 independent experiments normalised to the housekeeping protein GAPDH. Results are presented as mean ± -S.E.M., compared against respective control values obtained from cells incubated without cytokine. No differences were found. One-way ANOVA followed by Bonferroni. Fig. 7 . Pre-incubation with IL-4 blocks the reduction on the PRDX6 protein and mRNA levels induced by IFN-c and TNF-a in insulin-producing RINm5F cells. RINm5F cells were seeded 24 h before pre-incubation with 50 ng/mL of IL-4 for 24 h and after incubation with IFN-c and TNF-a for additional 24 h. After this period, cells were lysed and used for Western-Blotting or real-time PCR analyses. The (A) PRDX6 protein and (B) mRNA levels were analyzed after exposure of cells with cytokines. Different letters indicate statistically significant differences. P < 0.001. Data are expressed as mean ± S.E.M., normalised to the housekeeping GAPDH and represent 4 independent. Two-way ANOVA followed by Bonferroni.
79 ± 5% and 80 ± 2% for IFN-gamma, TNF-alpha or IFN-gamma + TNF-alpha exposure, respectively (Fig. 8B, white dotted bars) . The same effect is observed in cells exposed to increasing concentrations (25, 50, 100 e 200 lmol/L) of H 2 O 2 . Hydrogen peroxide is deleterious to RINm5F cells, as expected (Fig. 8B, black bars) . Nonetheless, after knockdown of PRDX6 by siRNA cells becomes much more susceptible to the deleterious effects of H 2 O 2 , with a decrease of more than 50% in cell viability at 100 lmol/L of H 2 O 2 (Fig. 8B, white dotted bar) compared to cells not treated with siRNA and exposed to the same concentration of H 2 O 2 (Fig. 8B, black bar) , and a maximum decrease in viability of 78 ± 1% at 200 lmol/L of H 2 O 2 compared to control cells, i.e., cells that were not exposed to either H 2 O 2 or PRDX6 siRNA (Fig. 8B, white bar) , what showed that PRDX6 is functionally relevant not only in protecting cells against diabetogenic cytokines but also in protecting cells against H 2 O 2 , which is the standard oxidative stressor in the biological context of pancreatic beta cells and diabetes. Another interesting point that can be depicted from these results is that the extension of the decrease in viability in cells treated with the combination of cytokines is similar to the extension comprised in the interval of 100-200 lmol/L of exposure to H 2 O 2 (Fig. 8B) .
Discussion
There is scarce information regarding the effects of either anti-or pro-inflammatory cytokines on the PRDXs expression in insulin-producing cells. The peroxiredoxin system encompasses six different isoforms of enzymes with thioredoxin-or glutathione-dependent peroxidase activity, but despite this diversity it appears that PRDXs have no redundant function (Knoops et al., 2007; Wang et al., 2003) . In the present study, we demonstrated that half of the peroxiredoxin isoforms are expressed at considerable protein levels in the insulin-producing RINm5F cell line, namely PRDX1, PRDX3, and PRDX6. Of these, only PRDX6 is negatively modulated by pro-inflammatory cytokines. All the remaining peroxiredoxins, i.e. PRDX1 and PRDX3, are constitutively expressed following the incubation conditions used. On the other hand, PRDX2, PRDX4, and PRDX5 proteins are either expressed at low levels, not detectable by the antibodies used, or not constitutively expressed at all in RINm5F cells. Although not further explored in the present work, the low expression levels of these PRDXs might account for the susceptibility of RINm5F cells to oxidative stress. Supporting this hypothesis, it has been demonstrated recently that overexpression of PRDX4, which is endoplasmic reticulum resident protein, protects RINm5F cells against hydrogen peroxide exposure (Mehmeti et al., 2012) .
IFN-gamma and TNF-alpha activate different intracellular signalling cascades (STAT1, and NF-kappaB and/or JNK/p38, respectively). The importance of the cross-talk among the different signalling pathways for the modulation of PRDX6, especially at the mRNA level, is documented convincingly in the present work, since only in combination IFN-gamma and TNF-alpha decrease PRDX6 mRNA levels. NF-kappaB has an essential role in this process, as when NF-kappaB migration into the nucleus is blocked, the PRDX6 mRNA decrease is prevented. Corroborating our results, it has already been shown that the PRDX6 promoter region has two putative NF-kappaB sites that contribute to the regulation of PRDX6 mRNA transcription in mice lens epithelial cells (Fatma et al., 2009 ). STAT1 and JNK pathway also decisively contribute to the reduction on the PRDX6 mRNA level in RINm5F cells. Indeed, after inhibition of the JNK or STAT1 pathways, the cytokine-induced decrease in PRDX6 level is blocked. Corroborating our data, other cell types exhibit some correlations between the JNK activation and PRDXs levels and activity (Han et al., 2005; Kim et al., 2008) . Hence, other transcription factors may be necessary to regulate PRDX6 expression in addition to NF-kappaB and STAT1, such as c-Jun, which is activated by the JNK signalling pathway. The reduction in PRDX6 protein level mediated by TFN-alpha and IFN-gamma is related to post-transcriptional proteolysis events, such as activation of the calpains and ubiquitinproteasome systems. Previous evidences for protein degradation by these two systems in other cell types and contexts have already been described for PRDX1 (Seo et al., 1999) , PRDX2 (Seo et al., 1999) , PRDX3 (Mukhopadhyay et al., 2006) , and PRDX4 (Roumes et al., 2010) . Additionally, using an in vitro yeast two hybrid system, evidence has been found for the interaction between PRDX6 and calpain (Budanova and Bystrova, 2008) . Hence, the control of the protein expression levels by proteolysis seems to be common for the majority (if not all) of the PRDXs, and it is demonstrated here for the first time that, for PRDX6, this is a regulated pathway that can be activated by the diabetogenic pro-inflammatory cytokines TNF-alpha and IFN-gamma, and blocked by IL-4. Direct activation of calpains have been observed in other cell types exposed to IFN-gamma (Hastie et al., 2008; Nozaki et al., 2010) , and it has been proposed that the calpain proteolysis system might be important for the activation of intracellular pathways by pro-inflammatory cytokines, like activation of NF-kappaB by TNF-alpha (Han PRDX6 by means of treatment with PRDX6 siRNA for 96 h. MTS conversion to a soluble formazan product by viable cells was determined kinetically at 490 nm. N = 6. Results are presented as mean ± S.E.M. Different letters indicate statistically significant differences. P < 0.001. Two-way ANOVA followed by Bonferroni. et al., 1999) , which could in turn modulate the expression of PRDX6.
IL-4 may be considered an anti-inflammatory cytokine in the context of the pancreatic beta cell, since it may protect these cells against the deleterious effects of pro-inflammatory cytokines (Kaminski et al., 2007 (Kaminski et al., , 2010 Souza et al., 2008) . IL-4 alone does not modulate PRDX1, PRDX3 nor PRDX6 protein levels or the level of any of the PRDXs mRNAs in the insulin-producing RINm5F cells. However, IL-4 is able to counteract the reduction induced by IFNgamma and TNF-alpha in PRDX6 mRNA and protein levels. It is known that beta cells express the IL-4 receptor and that IL-4 protects against pro-inflammatory-induced beta cell apoptosis via multiple mechanisms that may involve the activation of PI3K/Akt pathway, decreasing the activation of NF-kappaB, and decreasing the expression of iNOS, resulting in reduced caspase-3 activity and cytotoxicity (Kaminski et al., 2007 (Kaminski et al., , 2010 Souza et al., 2008) . Of note, IL-4 may prevent PRDX6 decrease by a dual mechanism involving blockade of PRDX6 proteolysis when cells are incubated with IFN-gamma and TNF-alpha separately and, additionally, the restoration of PRDX6 mRNA levels when cells are incubated with both pro-inflammatory cytokines in combination. However, it seems that IL-4 does not completely block proteolysis in the latter case, since the restoration of PRDX6 protein levels is not total when cells are incubated with both IFN-gamma and TNF-alpha in the presence of IL-4 (Fig. 7A) .
Hence the events leading to beta cell death are extremely complex. The relative importance of each cytokine alone or in combination is not fully known and the relative importance of ROS and RNS is not completely established (Jorns et al., 2005; Kaminski et al., 2007; Souza et al., 2008) . This is important topic as the cytokine milieu ultimately determines both the progression of intra-islet immune cells appearance/activation and also the production of ROS and RNS by pancreatic beta cells (Jorns et al., 2005; Kaminski et al., 2007; Souza et al., 2008) . A combination of oxidative and nitrosative stresses might be necessary for beta cell death in diabetes. However, evidence from animal models of diabetes indicate that IL-1beta causes dysfunction and death of beta cells, but surprisingly this seems not to be related to NO production (Todaro et al., 2003) . In this complex scenario, it is conceivable that the decrease in PRDX6 induced by TNF-alpha and IFN-gamma, alone or in combination, contributes to cellular damage, probably increasing susceptibility to hydrogen peroxide, but with no imperative need of cytokine-induced NO production. Corroborating this hypothesis, it is demonstrated in this work that PRDX6 has a functional role in the insulin-producing RINm5F cells, which is relevant for protection of cells against oxidative stress. We also know, from preliminary results, that PRDX6 down-regulation might increase sensitivity of pancreatic beta cell lineages to pro-inflammatory cytokines-induced apoptosis, which is further evidence of the importance of this peroxiredoxin for beta cell death pathways (results not shown). The relevance and final validation of our hypothesis to the diabetes development will have however to be complemented with isolated islets from future in vivo experiments. Use of PRDX6 knockdown mice seems a promising strategy. Fig. 9 . PRDX6 mRNA and protein levels and related intracellular pathways after exposure of RINm5F cells to anti-and pro-inflammatory cytokines. IFN-gamma-and TNFalpha-dependent down-regulation of PRDX6 protein level occurs through activation of proteolysis systems, such as calpains and proteasome, and activation of the JNK pathway. When these cytokines act in combination, they also decrease PRDX6 mRNA level, an effect that is dependent on the activation of major intracellular signalling pathways, namely STAT1 and NF-kappaB activated by IFN-gamma and TNF-alpha, respectively, and possibly JNK/c-Jun pathway modulated by both pro-inflammatory cytokines. It is not yet known whether down-regulation of PRDX6 mRNA by these transcription factors occurs directly by trans-repression or indirectly via expression of other regulatory mRNA and proteins. The anti-inflammatory cytokine IL-4 is able to counteract the IFN-gamma-and TNF-alpha-induced down-regulation of PRDX6, partially preventing PRDX6 proteolysis and totally recovering PRDX6 mRNA intracellular levels.
In summary, our results show that incubation of insulinproducing RINm5F cells with pro-inflammatory cytokines, namely IFN-gamma and TNF-alpha, leads to the down-regulation of PRDX6. No other peroxiredoxin isoforms are modulated by these cytokines. The regulation of PRDX6 intracellular levels encompasses two distinct events, proteolysis at the protein level and control of gene expression at the mRNA level. Only when used in combination do IFN-gamma and TNF-alpha decrease PRDX6 mRNA level, implying the need for a concomitant activation of different transcription factors and possibly other accessory proteins. Separately, IFN-gamma and TNF-alpha are able to reduce PRDX6 protein level but not mRNA level. There is a direct involvement of calpain proteases and the ubiquitin-proteasome system in this proteolytic process. NF-kappaB is involved in these events, at least when TNF-alpha signals into beta cells. Alone, the anti-inflammatory cytokine IL-4 does not modulate any of the PRDXs isoforms. However, IL-4 is able to counteract the reduction in the PRDX6 mRNA and protein levels induced by IFN-gamma and TNF-alpha. The molecular pathways involved in the PRDX6 modulation by cytokines are outlined in Fig. 9 . These results indicate that PRDX6 is important for protection of beta cells against oxidative stress and strengthen our knowledge regarding the relationship between anti-and pro-inflammatory intracellular signalling cascades in insulin-producing cells.
